Do S. Min
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Fermented Morinda citrifolia extract stimulates hair growth by promoting dermal papilla cell proliferation and modulating the follicular microenvironment.
Journal: Journal of ethnopharmacology
Published: May 27, 2026
PLD1 and PLD2 promote an immunosuppressive tumor microenvironment via CCL19-dependent macrophage polarization and PD-L1 induction.
Journal: Experimental & molecular medicine
Published: December 31, 2025
Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver.
Journal: Experimental & molecular medicine
Published: October 28, 2025
Correction to "Development and Evaluation of Indole-Based Phospholipase D Inhibitors for Lung Cancer Immunotherapy".
Journal: Journal of medicinal chemistry
Published: September 26, 2025
Monotropein improves late-onset hypogonadism in TM3 Leydig cells and aged rats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 22, 2025
Targeting cancer glutamine dependency with a first-in-class inhibitor of the mitochondrial glutamine transporter SLC1A5_var.
Journal: Nature communications
Published: June 03, 2025
Fermented Morinda citrifolia extract improves late-onset hypogonadism in aged rats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 21, 2025
Phospholipase D6 activates Wnt/β-catenin signaling through mitochondrial metabolic reprogramming to promote tumorigenesis in colorectal cancer.
Journal: Experimental & molecular medicine
Published: December 03, 2024
Development and Evaluation of Indole-Based Phospholipase D Inhibitors for Lung Cancer Immunotherapy.
Development and Evaluation of Indole-Based Phospholipase D Inhibitors for Lung Cancer Immunotherapy.
Journal: Journal of medicinal chemistry
Published: October 15, 2024
PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways.
Journal: Experimental & molecular medicine
Published: December 29, 2023
A newly developed PLD1 inhibitor ameliorates rheumatoid arthritis by regulating pathogenic T and B cells and inhibiting osteoclast differentiation.
Journal: Immunology letters
Published: March 17, 2023
Last Updated: 09/26/2026